Beyond PD-L1 IHC (TMB, Immune Microenvironment)

被引：0
|
作者：
Mino-Kenudsen, M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Tumor Mutation Burden; immune microenvironment; immune checkpoint inhibitor; BLOCKADE;
D O I：
10.1016/j.jtho.2019.08.216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IBS08.02
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [31] PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast
    Thompson, Elizabeth D.
    Taube, Janis M.
    Asch-Kendrick, Rebecca J.
    Ogurtsova, Aleksandra
    Xu, Haiying
    Sharma, Rajni
    Meeker, Alan
    Argani, Pedram
    Emens, Leisha A.
    Cimino-Mathews, Ashley
    MODERN PATHOLOGY, 2017, 30 (11) : 1551 - 1560
  • [32] PD-L1 Expression and the Immune Microenvironment in Primary Invasive Lobular Carcinomas of the Breast
    Thompson, Elizabeth
    Taube, Janis
    Asch-Kendrick, Rebecca J.
    Ogurtsova, Aleksandra
    Xu, Haiying
    Sharma, Rajni
    Meeker, Alan
    Argani, Pedram
    Emens, Leisha
    Cimino-Mathews, Ashley
    MODERN PATHOLOGY, 2016, 29 : 75A - 75A
  • [33] The Tumor-Immune Microenvironment and PD-L1 Expression in Acinar Prostatic Adenocarcinoma
    Hahn, Elan
    Xu, Bin
    Liu, Stanley K.
    Vesprini, Danny
    Downes, Michelle
    LABORATORY INVESTIGATION, 2018, 98 : 347 - 347
  • [34] The Tumor-Immune Microenvironment and PD-L1 Expression in Acinar Prostatic Adenocarcinoma
    Hahn, Elan
    Xu, Bin
    Liu, Stanley K.
    Vesprini, Danny
    Downes, Michelle
    MODERN PATHOLOGY, 2018, 31 : 347 - 347
  • [35] PD-L1 Expression and the Immune Microenvironment in Primary Invasive Lobular Carcinomas of the Breast
    Thompson, Elizabeth
    Taube, Janis
    Asch-Kendrick, Rebecca J.
    Ogurtsova, Aleksandra
    Xu, Haiying
    Sharma, Rajni
    Meeker, Alan
    Argani, Pedram
    Emens, Leisha
    Cimino-Mathews, Ashley
    LABORATORY INVESTIGATION, 2016, 96 : 75A - 75A
  • [36] Comparison the results from PD-L1 IHC and PD-L1 multiplex immunofluorescence for the prediction of anti-PD-1 immunotherapeutic response
    Sun, Hongzhe
    Liu, Xia
    Jiao, Tao
    Guo, Qian
    Du, Haizhen
    Han, Shuo
    Zhu, Lin
    Zhang, Zhifu
    Kong, Yan
    Li, Na
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1
    Guo, Jiazheng
    Yu, Fengyi
    Zhang, Kuojun
    Jiang, Sheng
    Zhang, Xiangyu
    Wang, Tianyu
    RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1096 - 1108
  • [38] The efficacy of PD-L1 blockade on PD-L1 negative medulloblastoma is dependent on timing and the tumor microenvironment
    Allen, Frederick
    Dorand, Rodney Dixon
    Rauhe, Peter
    Petrosiute, Agne
    Huang, Alex Y.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [39] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2015, 121 : 251 - 259
  • [40] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
12345